Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis

Stopped The main objective of this study has been achieved. Following internal discussions, the sponsor has decided to terminate this study early.

Conditions

• Myocardial Perfusion Imaging
• Diagnostic Certainty
• Stable Coronary Artery Disease

Interventions

• DRUG: XTR004

Sponsor

Sinotau Pharmaceutical Group